FDA Management of a High-Performance Computing Environment
*Applications will be reviewed on a rolling-basis.
A research opportunity is currently available with the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration located in Silver Spring, Maryland.
The FDA, an agency within the U.S. Department of Health and Human Services, promotes public health by assuring the safety and effectiveness of drugs, vaccines and medical devices. The Office of Science and Engineering Laboratories (CDRH/OSEL) accelerates patient access to innovative, safe and effective devices through best-in-the-world regulatory science.
The Division of Imaging, Diagnostics, and Software Reliability (DIDSR) develops methods for evaluating emerging medical imaging systems. Our research programs directly impact FDA’s regulatory assessments in areas including * AI/ML * WSI and digital pathology * Extended-reality (AR/VR) devices * Clinical trial design * In silico trials * Imaging physics. For more information, visit: https://www.fda.gov/about-fda/cdrh-offices/office-science-and-engineering-laboratories.
This training fellowship will support the design and management of a high-performance computing environment (HPC). The project will also support scientific and regulatory computing within FDA. The participant will be apart of an interdisciplinary team in managing the HPC environment with tasks including system management, automation and tuning of hardware and software systems, and user support for complex scientific and regulatory science applications.
Under the guidance of a mentor, the participant will be trained in: performing High-Performance Computing System Administration, including operating system automation and tuning, system diagnosis, performance monitoring, hardware design and implementation.
Anticipated Appointment Start Date: June 14, 2021; start date is flexible
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.
FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
- Non-employee nature of the ORISE appointment;
- Prohibition on ORISE Fellows performing inherently governmental functions;
- Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship;
- The fact that research materials and laboratory notebooks are the property of the FDA;
- ORISE fellow’s obligation to protect and not to further disclose or use non-public information.
If you have questions, send an email to ORISE.FDA.CDRH@orau.org. Please include the reference code (FDA-CDRH-2021-0014) for this opportunity in your email.